Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Siam Bheasaj is a leading Thai pharmaceutical company established in 1947, specializing in the development and manufacture of high-quality generic medicines. The company operates state-of-the-art facilities that are certified under international PIC/S GMP standards, ensuring safe and effective production for both domestic and export markets. Its diverse product portfolio spans multiple therapeutic areas, including cardiology, infectious diseases, respiratory health, and gastroenterology. In addition to its proprietary generic brands, Siam Bheasaj serves as a significant contract manufacturing organization (CMO) for several multinational pharmaceutical corporations. The company is recognized for its commitment to research and development, focusing on bioequivalence studies to ensure its products match the efficacy of original research drugs. Headquartered in Bangkok, Siam Bheasaj remains one of the largest and most respected local pharmaceutical entities in Southeast Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Siam Bheasach.